{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:21:26Z","timestamp":1747207286026,"version":"3.40.5"},"reference-count":106,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNSAMC"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>Alzheimer's disease (AD) is a form of brain degeneration that gradually impairs a\nperson's memory and cognitive skills, eventually making it harder for them to perform everyday\nactivities. Its pathophysiology has been attributed to the deposition of amyloid \u03b2 (A\u03b2),\nneurofibrillary tangles (NFT), and \u03b1-synuclein (A-s) in some cases. Presently, 4 drugs have been\napproved for the treatment. They are Donepezil, Rivastigmine, Galantamine and Memantine. The\nfirst three are acetylcholinesterase inhibitors, while memantine is an NMDA receptor antagonist.\nEven though these medications are successful in treating mild to moderate Alzheimer's disease,\nthey have not been able to reverse the disease or even slow its progression completely. Hence,\nnatural products are gaining more popularity due to the advantage of the multitarget intervention\neffect. The most investigated spice, Curcuma longa's bioactive component, curcumin, has\ndemonstrated anti-amyloid, anti-NFT, and anti-Lewy body properties and substantial antiinflammatory,\nantioxidant, and antiapoptotic properties. However, its proven neuroprotective\nactivity is hampered by many factors, such as poor water solubility and bioavailability. Therefore,\nmany novel formulations have been designed to improve its bioavailability with methods such as 1)\nMicellar Solubilization, 2) Cyclodextrin Complexation, 3) Crystal Modification, and 4) Particle\nSize Reduction, etc. The current chapter aims to summarize various novel formulations of curcumin\nand their effectiveness in treating AD.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0118715249279534240214111155","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T04:55:49Z","timestamp":1709009749000},"page":"281-293","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effectiveness of Novel Drug Delivery System using Curcumin in\nAlzheimer\u2019s Disease"],"prefix":"10.2174","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4566-7453","authenticated-orcid":true,"given":"Urmila","family":"Aswar","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Poona College of Pharmacy, Bharati Vidyapeeth, (Deemed to be University), Pune,\nMaharashtra, 411038, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3755-1784","authenticated-orcid":true,"given":"Kundlik","family":"Rathod","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Poona College of Pharmacy, Bharati Vidyapeeth, (Deemed to be University), Pune,\nMaharashtra, 411038, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dyandevi","family":"Mathure","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Poona College of Pharmacy, Bharati Vidyapeeth, (Deemed to be University), Pune,\nMaharashtra, 411038, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.937486","volume":"14","author":"Li X.","year":"2022","unstructured":"Li X.; Feng X.; Sun X.; Hou N.; Han F.; Liu Y.; Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990\u20132019. Front Aging Neurosci  2022,14","journal-title":"Front Aging Neurosci"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/alz.13016","volume":"19","year":"2023","unstructured":"2023 Alzheimer\u2019s disease facts and figures. Alzheimers Dement  2023,19(4),1598-1695","journal-title":"Alzheimers Dement"},{"key":"ref=3","author":"Organization W.H.","year":"2012","unstructured":"Organization W.H.;  Dementia: a public health priority  2012","journal-title":"Dementia: a public health priority"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s13311-021-01146-y","volume":"19","author":"Trejo-Lopez J.A.","year":"2022","unstructured":"Trejo-Lopez J.A.; Yachnis A.T.; Prokop S.; Neuropathology of Alzheimer\u2019s disease. Neurotherapeutics  2022,19(1),173-185","journal-title":"Neurotherapeutics"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"5644","DOI":"10.1073\/pnas.0600549103","volume":"103","author":"Mahley R.W.","year":"2006","unstructured":"Mahley R.W.; Weisgraber K.H.; Huang Y.; Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer\u2019s disease. Proc Natl Acad Sci  2006,103(15),5644-5651","journal-title":"Proc Natl Acad Sci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.pneurobio.2008.03.002","volume":"85","author":"Wang J.Z.","year":"2008","unstructured":"Wang J.Z.; Liu F.; Microtubule-associated protein tau in development, degeneration and protection of neurons. Prog Neurobiol  2008,85(2),148-175","journal-title":"Prog Neurobiol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.arcmed.2012.10.012","volume":"43","author":"C\u00e1rdenas A.M.","year":"2012","unstructured":"C\u00e1rdenas A.M.; Ardiles A.O.; Barraza N.; Ba\u00e9z-Matus X.; Caviedes P.; Role of tau protein in neuronal damage in Alzheimer\u2019s disease and Down syndrome. Arch Med Res  2012,43(8),645-654","journal-title":"Arch Med Res"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/j.1471-4159.2009.06511.x","volume":"112","author":"Meraz-R\u00edos M.A.","year":"2010","unstructured":"Meraz-R\u00edos M.A.; Lira-De Le\u00f3n K.I.; Campos-Pe\u00f1a V.; De Anda-Hern\u00e1ndez M.A.; Mena-L\u00f3pez R.; Tau oligomers and aggregation in Alzheimer\u2019s disease. J Neurochem  2010,112(6),1353-1367","journal-title":"J Neurochem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/nn.2583","volume":"13","author":"Palop J.J.","year":"2010","unstructured":"Palop J.J.; Mucke L.; Amyloid-\u03b2\u2013induced neuronal dysfunction in Alzheimer\u2019s disease: From synapses toward neural networks. Nat Neurosci  2010,13(7),812-818","journal-title":"Nat Neurosci"},{"key":"ref=10","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13122","volume":"33","author":"Ferrer I.","year":"2023","unstructured":"Ferrer I.; Hypothesis review: Alzheimer\u2019s overture guidelines. Brain Pathol  2023,33(1)","journal-title":"Brain Pathol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fnagi.2018.00003","volume":"10","author":"Tewari D.","year":"2018","unstructured":"Tewari D.; Stankiewicz A.M.; Mocan A.; Sah A.N.; Tzvetkov N.T.; Huminiecki L.; Horba\u0144czuk J.O.; Atanasov A.G.; Ethnopharmacological approaches for dementia therapy and significance of natural products and herbal drugs. Front Aging Neurosci  2018,10,3","journal-title":"Front Aging Neurosci"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1177\/1073110518804230","volume":"46","author":"Haines J.L.","year":"2018","unstructured":"Haines J.L.; Alzheimer disease: Perspectives from epidemiology and genetics. J Law Med Ethics  2018,46(3),694-698","journal-title":"J Law Med Ethics"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2147\/CIA.S105769","volume":"11","author":"Giri M.","year":"2016","unstructured":"Giri M.; L\u00fc Y.; Zhang M.; Genes associated with Alzheimer\u2019s disease: An overview and current status. Clin Interv Aging  2016,11,665-681","journal-title":"Clin Interv Aging"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40478-018-0559-4","volume":"6","author":"Davidson Y.S.","year":"2018","unstructured":"Davidson Y.S.; Robinson A.; Prasher V.P.; Mann D.M.A.; The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer\u2019s disease in individuals with Down syndrome. Acta Neuropathol Commun  2018,6(1),56","journal-title":"Acta Neuropathol Commun"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"11282","DOI":"10.1073\/pnas.90.23.11282","volume":"90","author":"U\u00e9da K.","year":"1993","unstructured":"U\u00e9da K.; Fukushima H.; Masliah E.; Xia Y.; Iwai A.; Yoshimoto M.; Otero D.A.; Kondo J.; Ihara Y.; Saitoh T.; Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci  1993,90(23),11282-11286","journal-title":"Proc Natl Acad Sci"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nsmb.3194","volume":"23","author":"Tuttle M.D.","year":"2016","unstructured":"Tuttle M.D.; Comellas G.; Nieuwkoop A.J.; Covell D.J.; Berthold D.A.; Kloepper K.D.; Courtney J.M.; Kim J.K.; Barclay A.M.; Kendall A.; Wan W.; Stubbs G.; Schwieters C.D.; Lee V.M.Y.; George J.M.; Rienstra C.M.; Solid-state NMR structure of a pathogenic fibril of full-length human \u03b1-synuclein. Nat Struct Mol Biol  2016,23(5),409-415","journal-title":"Nat Struct Mol Biol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"4374","DOI":"10.1074\/jbc.M115.705095","volume":"291","author":"Samuel F.","year":"2016","unstructured":"Samuel F.; Flavin W.P.; Iqbal S.; Pacelli C.; Sri Renganathan S.D.; Trudeau L.E.; Campbell E.M.; Fraser P.E.; Tandon A.; Effects of serine 129 phosphorylation on \u03b1-synuclein aggregation, membrane association, and internalization. J Biol Chem  2016,291(9),4374-4385","journal-title":"J Biol Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13024-019-0329-1","volume":"14","author":"Meade R.M.","year":"2019","unstructured":"Meade R.M.; Fairlie D.P.; Mason J.M.; Alpha-synuclein structure and Parkinson\u2019s disease \u2013 lessons and emerging principles. Mol Neurodegener  2019,14(1),29","journal-title":"Mol Neurodegener"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13024-019-0320-x","volume":"14","author":"Twohig D.","year":"2019","unstructured":"Twohig D.; Nielsen H.M.; \u03b1-synuclein in the pathophysiology of Alzheimer\u2019s disease. Mol Neurodegener  2019,14(1),23","journal-title":"Mol Neurodegener"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3233\/JAD-2009-1179","volume":"18","author":"O\u2019Brien R.J.","year":"2009","unstructured":"O\u2019Brien R.J.; Resnick S.M.; Zonderman A.B.; Ferrucci L.; Crain B.J.; Pletnikova O.; Rudow G.; Iacono D.; Riudavets M.A.; Driscoll I.; Price D.L.; Martin L.J.; Troncoso J.C.; Neuropathologic studies of the Baltimore longitudinal study of aging (BLSA). J Alzheimers Dis  2009,18(3),665-675","journal-title":"J Alzheimers Dis"},{"key":"ref=21","author":"Melmon K.L.","year":"1992","unstructured":"Melmon K.L.; Morrelli H.F.;  Melmon and Morrelli\u2019s Clinical Pharmacology: Basic Principles in Therapeutics  1992","journal-title":"Melmon and Morrelli\u2019s Clinical Pharmacology: Basic Principles in Therapeutics"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.biopha.2018.06.147","volume":"106","author":"Agatonovic-Kustrin S.","year":"2018","unstructured":"Agatonovic-Kustrin S.; Kettle C.; Morton D.W.; A molecular approach in drug development for Alzheimer\u2019s disease. Biomed Pharmacother  2018,106,553-565","journal-title":"Biomed Pharmacother"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s13311-019-00767-8","volume":"16","author":"Singh S.K.","year":"2019","unstructured":"Singh S.K.; Srivastav S.; Castellani R.J.; Plascencia-Villa G.; Perry G.; Neuroprotective and antioxidant effect of ginkgo biloba extract against ad and other neurological disorders. Neurotherapeutics  2019,16(3),666-674","journal-title":"Neurotherapeutics"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1080\/14786419.2018.1496429","volume":"34","author":"Cao Y.","year":"2020","unstructured":"Cao Y.; Xu W.; Huang Y.; Zeng X.; Licochalcone B, a chalcone derivative from Glycyrrhiza inflata, as a multifunctional agent for the treatment of Alzheimer\u2019s disease. Nat Prod Res  2020,34(5),736-739","journal-title":"Nat Prod Res"},{"key":"ref=25","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001747.pub3","volume":"2006","author":"Loy C.","year":"2006","unstructured":"Loy C.; Schneider L.; Galantamine for Alzheimer\u2019s disease and mild cognitive impairment. Cochrane Database Syst Rev  2006,2006(1)","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/1472-6882-13-218","volume":"13","author":"Abd El-Wahab A.E.","year":"2013","unstructured":"Abd El-Wahab A.E.; Ghareeb D.A.; Sarhan E.E.M.; Abu-Serie M.M.; El Demellawy M.A.; In vitro biological assessment of berberis vulgaris and its active constituent, berberine: antioxidants, anti-acetylcholinesterase, anti-diabetic and anticancer effects. BMC Complement Altern Med  2013,13(1),218","journal-title":"BMC Complement Altern Med"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3233\/JAD-132483","volume":"40","author":"Saharan S.","year":"2014","unstructured":"Saharan S.; Mandal P.K.; The emerging role of glutathione in Alzheimer\u2019s disease. J Alzheimers Dis  2014,40(3),519-529","journal-title":"J Alzheimers Dis"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jep.2004.01.016","volume":"91","author":"Dhingra D.","year":"2004","unstructured":"Dhingra D.; Parle M.; Kulkarni S.K.; Memory enhancing activity of Glycyrrhiza glabra in mice. J Ethnopharmacol  2004,91(2-3),361-365","journal-title":"J Ethnopharmacol"},{"key":"ref=29","first-page":"885","volume":"10","author":"Chang K-H.","year":"2016","unstructured":"Chang K-H.; Chen I.C.; Lin H.Y.; Chen H.C.; Lin C.H.; Lin T.H.; Weng Y.T.; Chao C.Y.; Wu Y.R.; Lin J.Y.; Lee-Chen G.J.; Chen C.M.; The aqueous extract of Glycyrrhiza inflata can upregulate unfolded protein response-mediated chaperones to reduce tau misfolding in cell models of Alzheimer\u2019s disease. Drug Des Devel Ther  2016,10,885-896","journal-title":"Drug Des Devel Ther"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jep.2014.10.058","volume":"159","author":"Kanno H.","year":"2015","unstructured":"Kanno H.; Kawakami Z.; Tabuchi M.; Mizoguchi K.; Ikarashi Y.; Kase Y.; Protective effects of glycycoumarin and procyanidin B1, active components of traditional Japanese medicine yokukansan, on amyloid \u03b2 oligomer-induced neuronal death. J Ethnopharmacol  2015,159,122-128","journal-title":"J Ethnopharmacol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.pharmthera.2016.06.018","volume":"166","author":"Ikarashi Y.","year":"2016","unstructured":"Ikarashi Y.; Mizoguchi K.; Neuropharmacological efficacy of the traditional Japanese Kampo medicine yokukansan and its active ingredients. Pharmacol Ther  2016,166,84-95","journal-title":"Pharmacol Ther"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1212\/WNL.51.4.1000","volume":"51","author":"Chandra V.","year":"1998","unstructured":"Chandra V.; Prevalence of Alzheimer's disease and other dementias in rural India. The Indo-US study  1998,51(4),1000-1008","journal-title":"The Indo-US study"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.neulet.2006.08.018","volume":"407","author":"Subramanian S.","year":"2006","unstructured":"Subramanian S.; Sandhyarani B.; Shree A.N.D.; Murthy K.K.; Kalyani K.; Kumar S.P.; Pradeep; Noone, M.J.; Taly, A.B. Lower levels of cerebrospinal fluid amyloid \u00df (A\u00df) in non-demented Indian controls. Neurosci Lett  2006,407(2),121-123","journal-title":"Neurosci Lett"},{"key":"ref=34","first-page":"73","volume":"18","author":"Shankar T.N.","year":"1980","unstructured":"Shankar T.N.; Shantha N.V.; Ramesh H.P.; Murthy I.A.; Murthy V.S.; Toxicity studies on turmeric (Curcuma longa): acute toxicity studies in rats, guineapigs and monkeys. Indian J Exp Biol  1980,18(1),73-75","journal-title":"Indian J Exp Biol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/01635588609513894","volume":"8","author":"Nagabhushan M.","year":"1986","unstructured":"Nagabhushan M.; Bhide S.V.; Nonmutagenicity of curcumin and its antimutagenic action versus chili and capsaicin. Nutr Cancer  1986,8(3),201-210","journal-title":"Nutr Cancer"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s11064-009-0065-y","volume":"35","author":"Zhao J.","year":"2010","unstructured":"Zhao J.; Yu S.; Zheng W.; Feng G.; Luo G.; Wang L.; Zhao Y.; Curcumin improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats. Neurochem Res  2010,35(3),374-379","journal-title":"Neurochem Res"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.pharep.2017.07.014","volume":"70","author":"Bai X.J.","year":"2018","unstructured":"Bai X.J.; Hao J.T.; Wang J.; Zhang W.F.; Yan C.P.; Zhao J.H.; Zhao Z.Q.; Curcumin inhibits cardiac hypertrophy and improves cardiovascular function via enhanced Na +\/Ca 2+ exchanger expression after transverse abdominal aortic constriction in rats. Pharmacol Rep  2018,70(1),60-68","journal-title":"Pharmacol Rep"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13098-019-0437-7","volume":"11","author":"Hodaei H.","year":"2019","unstructured":"Hodaei H.; Adibian M.; Nikpayam O.; Hedayati M.; Sohrab G.; The effect of curcumin supplementation on anthropometric indices, insulin resistance and oxidative stress in patients with type 2 diabetes: A randomized, double-blind clinical trial. Diabetol Metab Syndr  2019,11(1),41","journal-title":"Diabetol Metab Syndr"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nn0403-345","volume":"6","author":"Puglielli L.","year":"2003","unstructured":"Puglielli L.; Tanzi R.E.; Kovacs D.M.; Alzheimer\u2019s disease: The cholesterol connection. Nat Neurosci  2003,6(4),345-351","journal-title":"Nat Neurosci"},{"key":"ref=40","first-page":"273","volume":"36","author":"Soni K.B.","year":"1992","unstructured":"Soni K.B.; Kuttan R.; Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J Physiol Pharmacol  1992,36(4),273-275","journal-title":"Indian J Physiol Pharmacol"},{"key":"ref=41","first-page":"201","volume":"40","author":"Alwi I.","year":"2008","unstructured":"Alwi I.; Santoso T.; Suyono S.; Sutrisna B.; Suyatna F.D.; Kresno S.B.; Ernie S.; The effect of curcumin on lipid level in patients with acute coronary syndrome. Acta Med Indones  2008,40(4),201-210","journal-title":"Acta Med Indones"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jep.2005.11.009","volume":"105","author":"Fan C.","year":"2006","unstructured":"Fan C.; Wo X.; Qian Y.; Yin J.; Gao L.; Effect of curcumin on the expression of LDL receptor in mouse macrophages. J Ethnopharmacol  2006,105(1-2),251-254","journal-title":"J Ethnopharmacol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0006-2952(99)00206-3","volume":"58","author":"Shah B.H.","year":"1999","unstructured":"Shah B.H.; Nawaz Z.; Pertani S.A.; Roomi A.; Mahmood H.; Saeed S.A.; Gilani A.H.; Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling. Biochem Pharmacol  1999,58(7),1167-1172","journal-title":"Biochem Pharmacol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/0049-3848(85)90276-2","volume":"40","author":"Srivastava R.","year":"1985","unstructured":"Srivastava R.; Dikshit M.; Srimal R.C.; Dhawan B.N.; Anti-thrombotic effect of curcumin. Thromb Res  1985,40(3),413-417","journal-title":"Thromb Res"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2174\/1568013033358761","volume":"3","author":"Cole G.","year":"2003","unstructured":"Cole G.; Yang F.; Lim G.; Cummings J.; Masterman D.; Frautschy S.; A rationale for curcuminoids for the prevention or treatment of Alzheimer\u2019s disease. Curr Med Chem Immunol Endocr Metab Agents  2003,3(1),15-25","journal-title":"Curr Med Chem Immunol Endocr Metab Agents"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/jnr.20025","volume":"75","author":"Ono K.","year":"2004","unstructured":"Ono K.; Hasegawa K.; Naiki H.; Yamada M.; Curcumin has potent anti\u2010amyloidogenic effects for Alzheimer\u2019s \u03b2\u2010amyloid fibrils in vitro. J Neurosci Res  2004,75(6),742-750","journal-title":"J Neurosci Res"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2174\/1567205053585882","volume":"2","author":"Ringman J.","year":"2005","unstructured":"Ringman J.; Frautschy S.; Cole G.; Masterman D.; Cummings J.; A potential role of the curry spice curcumin in Alzheimer\u2019s disease. Curr Alzheimer Res  2005,2(2),131-136","journal-title":"Curr Alzheimer Res"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"8370","DOI":"10.1523\/JNEUROSCI.21-21-08370.2001","volume":"21","author":"Lim G.P.","year":"2001","unstructured":"Lim G.P.; Chu T.; Yang F.; Beech W.; Frautschy S.A.; Cole G.M.; The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci  2001,21(21),8370-8377","journal-title":"J Neurosci"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/S0197-4580(01)00300-1","volume":"22","author":"Frautschy S.","year":"2001","unstructured":"Frautschy S.; Hu W.; Kim P.; Miller S.A.; Chu T.; Harris-White M.E.; Cole G.M.; Phenolic anti-inflammatory antioxidant reversal of A\u00ce-induced cognitive deficits and neuropathology. Neurobiol Aging  2001,22(6),993-1005","journal-title":"Neurobiol Aging"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1208\/s12248-012-9444-4","volume":"15","author":"Cheng K.K.","year":"2013","unstructured":"Cheng K.K.; Yeung C.F.; Ho S.W.; Chow S.F.; Chow A.H.L.; Baum L.; Highly stabilized curcumin nanoparticles tested in an in vitro blood-brain barrier model and in Alzheimer\u2019s disease Tg2576 mice. AAPS J  2013,15(2),324-336","journal-title":"AAPS J"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1007\/s11064-020-02992-6","volume":"45","author":"Lin L.","year":"2020","unstructured":"Lin L.; Li C.; Zhang D.; Yuan M.; Chen C.; Li M.; Synergic effects of berberine and curcumin on improving cognitive function in an Alzheimer\u2019s disease mouse model. Neurochem Res  2020,45(5),1130-1141","journal-title":"Neurochem Res"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.3390\/ijms21155459","volume":"21","author":"Su I.J.","year":"2020","unstructured":"Su I.J.; Chang H.Y.; Wang H.C.; Tsai K.J.; A curcumin analog exhibits multiple biologic effects on the pathogenesis of Alzheimer\u2019s disease and improves behavior, inflammation, and \u03b2-amyloid accumulation in a mouse model. Int J Mol Sci  2020,21(15),5459","journal-title":"Int J Mol Sci"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ptr.5030","volume":"28","author":"Ahmed T.","year":"2014","unstructured":"Ahmed T.; Gilani A.H.; Therapeutic potential of turmeric in Alzheimer\u2019s disease: Curcumin or curcuminoids? Phytother Res  2014,28(4),517-525","journal-title":"Phytother Res"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.bbrep.2015.10.009","volume":"4","author":"Yanagisawa D.","year":"2015","unstructured":"Yanagisawa D.; Taguchi H.; Morikawa S.; Kato T.; Hirao K.; Shirai N.; Tooyama I.; Novel curcumin derivatives as potent inhibitors of amyloid \u03b2 aggregation. Biochem Biophys Rep  2015,4,357-368","journal-title":"Biochem Biophys Rep"},{"key":"ref=55","first-page":"53","volume":"1","author":"Alattiya R.H.","year":"2021","unstructured":"Alattiya R.H.; The role of polyphenols in the treatment of alzheimer\u2019s disease: Curcumin as a prototype: Polyphenols in alzheimer\u2019s disease. AJMS  2021,1,53-61","journal-title":"AJMS"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"455","DOI":"10.4236\/ajps.2021.123030","volume":"12","author":"Sahoo J.P.","year":"2021","unstructured":"Sahoo J.P.; Behera L.; Praveena J.; Sawant S.; Mishra A.; Sharma S.S.; Ghosh L.; Mishra A.P.; Sahoo A.R.; Pradhan P.; Sahu S.; Moharana A.; Samal K.C.; The golden spice turmeric (Curcuma longa) and its feasible benefits in prospering human health\u2014a review. Am J Plant Sci  2021,12(3),455-475","journal-title":"Am J Plant Sci"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"6862","DOI":"10.1002\/ptr.7273","volume":"35","author":"Mohseni M.","year":"2021","unstructured":"Mohseni M.; Sahebkar A.; Askari G.; Johnston T.P.; Alikiaii B.; Bagherniya M.; The clinical use of curcumin on neurological disorders: An updated systematic review of clinical trials. Phytother Res  2021,35(12),6862-6882","journal-title":"Phytother Res"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.tifs.2017.12.004","volume":"72","author":"Silva A.C.","year":"2018","unstructured":"Silva A.C.; Santos P.D.F.; Silva J.T.P.; Leimann F.V.; Bracht L.; Gon\u00e7alves O.H.; Impact of curcumin nanoformulation on its antimicrobial activity. Trends Food Sci Technol  2018,72,74-82","journal-title":"Trends Food Sci Technol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"117","DOI":"10.15420\/ecr.2019.17.2","volume":"14","author":"Shimizu K.","year":"2019","unstructured":"Shimizu K.; Funamoto M.; Sunagawa Y.; Shimizu S.; Katanasaka Y.; Miyazaki Y.; Wada H.; Hasegawa K.; Morimoto T.; Anti-inflammatory action of curcumin and its use in the treatment of lifestyle-related diseases. Eur Cardiol  2019,14(2),117-122","journal-title":"Eur Cardiol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2019.02.020","volume":"406","author":"Abrahams S.","year":"2019","unstructured":"Abrahams S.; Haylett W.L.; Johnson G.; Carr J.A.; Bardien S.; Antioxidant effects of curcumin in models of neurodegeneration, aging, oxidative and nitrosative stress A review.. Neuroscience  2019,406,1-21","journal-title":"Neuroscience"},{"key":"ref=61","first-page":"217","volume":"11","author":"Mor N.","year":"2021","unstructured":"Mor N.; Raghav N.; A comprehensive update on successful clinical trials of curcumin. Chem Biol Interface  2021,11(6),217","journal-title":"Chem Biol Interface"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3389\/fbioe.2020.00879","volume":"8","author":"Gupta T.","year":"2020","unstructured":"Gupta T.; Singh J.; Kaur S.; Sandhu S.; Singh G.; Kaur I.P.; Enhancing bioavailability and stability of curcumin using solid lipid nanoparticles (CLEN): A covenant for its effectiveness. Front Bioeng Biotechnol  2020,8,879","journal-title":"Front Bioeng Biotechnol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"14044","DOI":"10.3390\/ijms241814044","volume":"24","author":"Puranik N.","year":"2023","unstructured":"Puranik N.; Yadav D.; Song M.; Advancements in the application of nanomedicine in Alzheimer\u2019s Disease: A therapeutic perspective. Int J Mol Sci  2023,24(18),14044","journal-title":"Int J Mol Sci"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.drudis.2018.11.001","volume":"24","author":"Wang Z.Y.","year":"2019","unstructured":"Wang Z.Y.; Sreenivasmurthy S.G.; Song J.X.; Liu J.Y.; Li M.; Strategies for brain-targeting liposomal delivery of small hydrophobic molecules in the treatment of neurodegenerative diseases. Drug Discov Today  2019,24(2),595-605","journal-title":"Drug Discov Today"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/jps.21079","volume":"97","author":"Cheng Y.","year":"2008","unstructured":"Cheng Y.; Xu Z.; Ma M.; Xu T.; Dendrimers as drug carriers: Applications in different routes of drug administration. J Pharm Sci  2008,97(1),123-143","journal-title":"J Pharm Sci"},{"key":"ref=66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102867","volume":"66","author":"Seko I.","year":"2021","unstructured":"Seko I.; Tonbul H.; Tavuk\u00e7uo\u011flu E.; \u015eahin A.; Akbas S.; Yan\u0131k H.; \u00d6zt\u00fcrk S.C.; Esendagli G.; Khan M.; Capan Y.; Development of curcumin and docetaxel co-loaded actively targeted PLGA nanoparticles to overcome blood brain barrier. J Drug Deliv Sci Technol  2021,66","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3233\/JAD-2012-112141","volume":"30","author":"Doggui S.","year":"2012","unstructured":"Doggui S.; Sahni J.K.; Arseneault M.; Dao L.; Ramassamy C.; Neuronal uptake and neuroprotective effect of curcumin-loaded PLGA nanoparticles on the human SK-N-SH cell line. J Alzheimers Dis  2012,30(2),377-392","journal-title":"J Alzheimers Dis"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12951-020-00626-1","volume":"18","author":"Gao C.","year":"2020","unstructured":"Gao C.; Chu X.; Gong W.; Zheng J.; Xie X.; Wang Y.; Yang M.; Li Z.; Gao C.; Yang Y.; RETRACTED ARTICLE: Neuron tau-targeting biomimetic nanoparticles for curcumin delivery to delay progression of Alzheimer\u2019s disease. J Nanobiotechnology  2020,18(1),71","journal-title":"J Nanobiotechnology"},{"key":"ref=69","first-page":"434","volume":"83","author":"Marslin G.","year":"2017","unstructured":"Marslin G.; Sarmento B.F.; Franklin G.; Martins J.A.; Silva C.J.; Gomes A.F.; S\u00e1rria M.P.; Coutinho O.M.; Dias A.C.; Curcumin encapsulated into methoxy poly (ethylene glycol) poly (\u03b5-caprolactone) nanoparticles increases cellular uptake and neuroprotective effect in glioma cells. Planta Med  2017,83(5),434-444","journal-title":"Planta Med"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ijpharm.2017.05.015","volume":"526","author":"Barbara R.","year":"2017","unstructured":"Barbara R.; Belletti D.; Pederzoli F.; Masoni M.; Keller J.; Ballestrazzi A.; Vandelli M.A.; Tosi G.; Grabrucker A.M.; Novel curcumin loaded nanoparticles engineered for blood-brain barrier crossing and able to disrupt abeta aggregates. Int J Pharm  2017,526(1-2),413-424","journal-title":"Int J Pharm"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1021\/nn405077y","volume":"8","author":"Tiwari S.K.","year":"2014","unstructured":"Tiwari S.K.; Agarwal S.; Seth B.; Yadav A.; Nair S.; Bhatnagar P.; Karmakar M.; Kumari M.; Chauhan L.K.S.; Patel D.K.; Srivastava V.; Singh D.; Gupta S.K.; Tripathi A.; Chaturvedi R.K.; Gupta K.C.; Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer\u2019s disease model via canonical Wnt\/\u03b2-catenin pathway. ACS Nano  2014,8(1),76-103","journal-title":"ACS Nano"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"81001","DOI":"10.18632\/oncotarget.20944","volume":"8","author":"Huang N.","year":"2017","unstructured":"Huang N.; Lu S.; Liu X.G.; Zhu J.; Wang Y.J.; Liu R.T.; PLGA nanoparticles modified with a BBB-penetrating peptide co-delivering A\u03b2 generation inhibitor and curcumin attenuate memory deficits and neuropathology in Alzheimer\u2019s disease mice. Oncotarget  2017,8(46),81001-81013","journal-title":"Oncotarget"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.bbamem.2010.09.007","volume":"1808","author":"Khumsupan P.","year":"2011","unstructured":"Khumsupan P.; Ramirez R.; Khumsupan D.; Narayanaswami V.; Apolipoprotein E LDL receptor-binding domain-containing high-density lipoprotein: A nanovehicle to transport curcumin, an antioxidant and anti-amyloid bioflavonoid. Biochim Biophys Acta Biomembr  2011,1808(1),352-359","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3233\/JAD-2010-101374","volume":"23","author":"Ray B.","year":"2011","unstructured":"Ray B.; Bisht S.; Maitra A.; Maitra A.; Lahiri D.K.; Neuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc\u2122) in the neuronal cell culture and animal model: Implications for Alzheimer\u2019s disease. J Alzheimers Dis  2011,23(1),61-77","journal-title":"J Alzheimers Dis"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.nano.2011.06.015","volume":"7","author":"Taylor M.","year":"2011","unstructured":"Taylor M.; Moore S.; Mourtas S.; Niarakis A.; Re F.; Zona C.; Ferla B.L.; Nicotra F.; Masserini M.; Antimisiaris S.G.; Gregori M.; Allsop D.; Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer\u2019s A\u03b2 peptide. Nanomedicine  2011,7(5),541-550","journal-title":"Nanomedicine"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.addr.2006.09.009","volume":"58","author":"Torchilin V.","year":"2006","unstructured":"Torchilin V.; Multifunctional nanocarriers. Adv Drug Deliv Rev  2006,58(14),1532-1555","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/zaac.19976230806","volume":"623","author":"K\u00fchlwein F.","year":"1997","unstructured":"K\u00fchlwein F.; Polborn K.; Beck W.; Metallkomplexe von farbstoffen. VIII \u00fcbergangsmetallkomplexe des curcumins und seiner derivate. Z Anorg Allg Chem  1997,623(8),1211-1219","journal-title":"Z Anorg Allg Chem"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"4986","DOI":"10.1039\/C5CS00088B","volume":"44","author":"Wanninger S.","year":"2015","unstructured":"Wanninger S.; Lorenz V.; Subhan A.; Edelmann F.T.; Metal complexes of curcumin \u2013 synthetic strategies, structures and medicinal applications. Chem Soc Rev  2015,44(15),4986-5002","journal-title":"Chem Soc Rev"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.freeradbiomed.2003.09.011","volume":"35","author":"Vajragupta O.","year":"2003","unstructured":"Vajragupta O.; Boonchoong P.; Watanabe H.; Tohda M.; Kummasud N.; Sumanont Y.; Manganese complexes of curcumin and its derivatives: Evaluation for the radical scavenging ability and neuroprotective activity. Free Radic Biol Med  2003,35(12),1632-1644","journal-title":"Free Radic Biol Med"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3390\/ijms22010196","volume":"22","author":"Shabbir U.","year":"2020","unstructured":"Shabbir U.; Rubab M.; Tyagi A.; Oh D.H.; Curcumin and its derivatives as theranostic agents in Alzheimer\u2019s disease: The implication of nanotechnology. Int J Mol Sci  2020,22(1),196","journal-title":"Int J Mol Sci"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1208\/s12249-017-0832-z","volume":"19","author":"Alves T.F.","year":"2018","unstructured":"Alves T.F.; Chaud M.V.; Grotto D.; Jozala A.F.; Pandit R.; Rai M.; dos Santos C.A.; Association of silver nanoparticles and curcumin solid dispersion: Antimicrobial and antioxidant properties. AAPS PharmSciTech  2018,19(1),225-231","journal-title":"AAPS PharmSciTech"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.tifs.2017.11.009","volume":"71","author":"Araiza-Calahorra A.","year":"2018","unstructured":"Araiza-Calahorra A.; Akhtar M.; Sarkar A.; Recent advances in emulsion-based delivery approaches for curcumin: From encapsulation to bioaccessibility. Trends Food Sci Technol  2018,71,155-169","journal-title":"Trends Food Sci Technol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.jcis.2007.05.080","volume":"314","author":"Sripriya R.","year":"2007","unstructured":"Sripriya R.; Muthu Raja K.; Santhosh G.; Chandrasekaran M.; Noel M.; The effect of structure of oil phase, surfactant and co-surfactant on the physicochemical and electrochemical properties of bicontinuous microemulsion. J Colloid Interface Sci  2007,314(2),712-717","journal-title":"J Colloid Interface Sci"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3109\/1061186X.2012.719230","volume":"20","author":"Wang S.","year":"2012","unstructured":"Wang S.; Chen P.; Zhang L.; Yang C.; Zhai G.; Formulation and evaluation of microemulsion-based in situ ion-sensitive gelling systems for intranasal administration of curcumin. J Drug Target  2012,20(10),831-840","journal-title":"J Drug Target"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3109\/1061186X.2013.876644","volume":"22","author":"Sood S.","year":"2014","unstructured":"Sood S.; Jain K.; Gowthamarajan K.; Intranasal therapeutic strategies for management of Alzheimer\u2019s disease. J Drug Target  2014,22(4),279-294","journal-title":"J Drug Target"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1246\/bcsj.20200304","volume":"94","author":"Kato T.","year":"2021","unstructured":"Kato T.; Gupta M.; Yamaguchi D.; Gan K.P.; Nakayama M.; Supramolecular association and nanostructure formation of liquid crystals and polymers for new functional materials. Bull Chem Soc Jpn  2021,94(1),357-376","journal-title":"Bull Chem Soc Jpn"},{"key":"ref=87","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5538940","volume":"2021","author":"Tlijani M.","year":"2021","unstructured":"Tlijani M.; Development of a BCS class II drug microemulsion for oral delivery: Design, optimization, and evaluation. J Nanomater  2021,2021","journal-title":"J Nanomater"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2174\/157341311794480282","volume":"7","author":"Shinde L.R.","year":"2011","unstructured":"Shinde L.R.; Jindal A.B.; Devarajan P.V.; Microemulsions and nanoemulsions for targeted drug delivery to the brain. Curr Nanosci  2011,7(1),119-133","journal-title":"Curr Nanosci"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s43094-022-00441-5","volume":"8","author":"Patil V.","year":"2022","unstructured":"Patil V.; Mhamane S.; More S.; Pawar A.; Arulmozhi S.; Exploring the protective effect exhibited by curcumin-loaded coconut oil microemulsion in the experimental models of neurodegeneration: An insight of formulation development, in vitro and in vivo study. Futur J Pharm Sci  2022,8(1),51","journal-title":"Futur J Pharm Sci"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1055\/s-2006-957450","volume":"64","author":"Shoba G.","year":"1998","unstructured":"Shoba G.; Joy D.; Joseph T.; Majeed M.; Rajendran R.; Srinivas P.; Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med  1998,64(4),353-356","journal-title":"Planta Med"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.progpolymsci.2006.03.002","volume":"31","author":"Yu L.","year":"2006","unstructured":"Yu L.; Dean K.; Li L.; Polymer blends and composites from renewable resources. Prog Polym Sci  2006,31(6),576-602","journal-title":"Prog Polym Sci"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"261","DOI":"10.5772\/intechopen.76041","author":"Hernandez-Patlan D.","year":"2018","unstructured":"Hernandez-Patlan D.; Chitoneous materials for control of foodborne pathogens and mycotoxins in poultry. Chitin-Chitosan: Myriad Functionalities in Science and Technology  2018,261-282","journal-title":"Chitin-Chitosan: Myriad Functionalities in Science and Technology"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jcis.2011.12.063","volume":"370","author":"Mazzarino L.","year":"2012","unstructured":"Mazzarino L.; Travelet C.; Ortega-Murillo S.; Otsuka I.; Pignot-Paintrand I.; Lemos-Senna E.; Borsali R.; Elaboration of chitosan-coated nanoparticles loaded with curcumin for mucoadhesive applications. J Colloid Interface Sci  2012,370(1),58-66","journal-title":"J Colloid Interface Sci"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.ijbiomac.2014.08.052","volume":"72","author":"Sarvaiya J.","year":"2015","unstructured":"Sarvaiya J.; Agrawal Y.K.; Chitosan as a suitable nanocarrier material for anti-Alzheimer drug delivery. Int J Biol Macromol  2015,72,454-465","journal-title":"Int J Biol Macromol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1007\/s13346-018-0570-0","volume":"8","author":"Parikh A.","year":"2018","unstructured":"Parikh A.; Kathawala K.; Li J.; Chen C.; Shan Z.; Cao X.; Zhou X.F.; Garg S.; Curcumin-loaded self-nanomicellizing solid dispersion system: Part II: in vivo safety and efficacy assessment against behavior deficit in Alzheimer disease. Drug Deliv Transl Res  2018,8(5),1406-1420","journal-title":"Drug Deliv Transl Res"},{"key":"ref=96","first-page":"80","volume":"1","author":"Hagl S.","year":"2014","unstructured":"Hagl S.; Heinrich M.; Kocher A.; Schiborr C.; Frank J.; Eckert G.P.; Curcumin micelles improve mitochondrial function in a mouse model of Alzheimer\u2019s disease. J Prev Alzheimers Dis  2014,1(2),80-83","journal-title":"J Prev Alzheimers Dis"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3233\/JAD-160289","volume":"55","author":"McClure R.","year":"2016","unstructured":"McClure R.; Ong H.; Janve V.; Barton S.; Zhu M.; Li B.; Dawes M.; Jerome W.G.; Anderson A.; Massion P.; Gore J.C.; Pham W.; Aerosol delivery of curcumin reduced amyloid-\u03b2 deposition and improved cognitive performance in a transgenic model of Alzheimer\u2019s disease. J Alzheimers Dis  2016,55(2),797-811","journal-title":"J Alzheimers Dis"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-2006-10101","volume":"10","author":"Zhang L.","year":"2006","unstructured":"Zhang L.; Fiala M.; Cashman J.; Sayre J.; Espinosa A.; Mahanian M.; Zaghi J.; Badmaev V.; Graves M.C.; Bernard G.; Rosenthal M.; Curcuminoids enhance amyloid-\u03b2 uptake by macrophages of Alzheimer\u2019s disease patients. J Alzheimers Dis  2006,10(1),1-7","journal-title":"J Alzheimers Dis"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jddst.2015.08.005","volume":"29","author":"Gangurde A.B.","year":"2015","unstructured":"Gangurde A.B.; Kundaikar H.S.; Javeer S.D.; Jaiswar D.R.; Degani M.S.; Amin P.D.; Enhanced solubility and dissolution of curcumin by a hydrophilic polymer solid dispersion and its in silico molecular modeling studies. J Drug Deliv Sci Technol  2015,29,226-237","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/bmc.1244","volume":"23","author":"Li J.","year":"2009","unstructured":"Li J.; Jiang Y.; Wen J.; Fan G.; Wu Y.; Zhang C.; A rapid and simple HPLC method for the determination of curcumin in rat plasma: assay development, validation and application to a pharmacokinetic study of curcumin liposome. Biomed Chromatogr  2009,23(11),1201-1207","journal-title":"Biomed Chromatogr"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/j.cclet.2017.06.024","volume":"28","author":"Ji W.H.","year":"2017","unstructured":"Ji W.H.; Xiao Z-B.; Liu G-Y.; Zhang X.; Development and application of nano-flavor-drug carriers in neurodegenerative diseases. Chin Chem Lett  2017,28(9),1829-1834","journal-title":"Chin Chem Lett"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jconrel.2017.05.019","volume":"260","author":"Agrawal M.","year":"2017","unstructured":"Agrawal M.; Ajazuddin; Tripathi, D.K.; Saraf, S.; Saraf, S.; Antimisiaris, S.G.; Mourtas, S.; Hammarlund-Udenaes, M.; Alexander, A. Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer\u2019s disease. J Control Release  2017,260,61-77","journal-title":"J Control Release"},{"key":"ref=103","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119476","volume":"585","author":"Askarizadeh A.","year":"2020","unstructured":"Askarizadeh A.; Barreto G.E.; Henney N.C.; Majeed M.; Sahebkar A.; Neuroprotection by curcumin: A review on brain delivery strategies. Int J Pharm  2020,585","journal-title":"Int J Pharm"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1080\/02652048.2020.1756971","volume":"37","author":"Kaur A.","year":"2020","unstructured":"Kaur A.; Nigam K.; Srivastava S.; Tyagi A.; Dang S.; Memantine nanoemulsion: A new approach to treat Alzheimer\u2019s disease. J Microencapsul  2020,37(5),355-365","journal-title":"J Microencapsul"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"4866","DOI":"10.3390\/molecules25204866","volume":"25","author":"Manek E.","year":"2020","unstructured":"Manek E.; Darvas F.; Petroianu G.A.; Use of biodegradable, chitosan-based nanoparticles in the treatment of Alzheimer\u2019s disease. Molecules  2020,25(20),4866","journal-title":"Molecules"},{"key":"ref=106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032616","volume":"7","author":"Mathew A.","year":"2012","unstructured":"Mathew A.; Fukuda T.; Nagaoka Y.; Hasumura T.; Morimoto H.; Yoshida Y.; Maekawa T.; Venugopal K.; Kumar D.S.; Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer\u2019s disease. PLoS One  2012,7(3)","journal-title":"PLoS One"}],"container-title":["Central Nervous System Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715249279534240214111155","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/227361\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715249279534240214111155","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T06:33:36Z","timestamp":1728628416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/227361\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":106,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0118715249279534240214111155","relation":{},"ISSN":["1871-5249"],"issn-type":[{"type":"print","value":"1871-5249"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-10-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}